Germany vs Iceland: Pharmaceutical consumption

Germany
252.5 Defined daily dose per 1 000 inhabitants per day
in 2024
Iceland
236.8 Defined daily dose per 1 000 inhabitants per day
in 2025
Germany rank
14th
Iceland rank
17th

Pharmaceutical consumption over time

  • Germany
  • Iceland
0100200300198620052025

How they compare

Germany currently reports 252.5 Defined daily dose per 1 000 inhabitants per day against 236.8 Defined daily dose per 1 000 inhabitants per day in Iceland, a difference of 15.7 Defined daily dose per 1 000 inhabitants per day.

That makes Germany's figure about 1.1 times Iceland's.

The two have swapped places 1 time across 36 shared years of data; in 1989 it was Iceland ahead.

Germany ranks 14th and Iceland ranks 17th of 21 countries.

Across the 5 decades both report, Germany averaged higher in 4 and Iceland in 1.

Head to head by decade

Decade Germany Iceland Difference Ahead
1980s 119.5 Defined daily dose per 1 000 inhabitants per day 154.2 Defined daily dose per 1 000 inhabitants per day 34.7 Defined daily dose per 1 000 inhabitants per day Iceland
1990s 141.84 Defined daily dose per 1 000 inhabitants per day 121.34 Defined daily dose per 1 000 inhabitants per day 20.5 Defined daily dose per 1 000 inhabitants per day Germany
2000s 152.86 Defined daily dose per 1 000 inhabitants per day 114.12 Defined daily dose per 1 000 inhabitants per day 38.74 Defined daily dose per 1 000 inhabitants per day Germany
2010s 218.73 Defined daily dose per 1 000 inhabitants per day 155.73 Defined daily dose per 1 000 inhabitants per day 63 Defined daily dose per 1 000 inhabitants per day Germany
2020s 242.66 Defined daily dose per 1 000 inhabitants per day 208.98 Defined daily dose per 1 000 inhabitants per day 33.68 Defined daily dose per 1 000 inhabitants per day Germany

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pharmaceutical consumption, Germany or Iceland?
Germany, at 252.5 Defined daily dose per 1 000 inhabitants per day against 236.8 Defined daily dose per 1 000 inhabitants per day in Iceland as of 2024.
What is the difference in pharmaceutical consumption between Germany and Iceland?
15.7 Defined daily dose per 1 000 inhabitants per day, with Germany ahead.
How many years of comparable data are there for Germany and Iceland?
36 years are reported by both, from 1989 to 2024.
How do Germany and Iceland rank globally for pharmaceutical consumption?
Germany ranks 14th and Iceland ranks 17th of 21 countries.
Where does this data come from?
Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Germany vs Iceland: Pharmaceutical consumption. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 20 August 2026, from https://health.statizoid.com/compare/pharmaceutical-consumption/germany/iceland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/compare/pharmaceutical-consumption/germany/iceland/">Germany vs Iceland: Pharmaceutical consumption</a> — Statizoid

About this data

Indicator
Pharmaceutical consumption
Unit
Defined daily dose per 1 000 inhabitants per day
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
31 places, 708 data points, 1980–2025
Last refreshed

Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.